Supplementary table 1-4

Published: 7 October 2024| Version 1 | DOI: 10.17632/rt52x6gprb.1
Contributor:
Annelie Musters

Description

Supplementary Table 1. Number of patients receiving different doses of systemic treatments (used as a single agent systemic therapy, i.e. systemic monotherapy) Supplementary Table 2. Number of patients receiving different doses of systemic treatments (when used as combination systemic therapy) Supplementary Table 3. Comparison of COVID-19 outcomes in those treated with topical treatment or a single systemic therapy (monotherapy analysis) Supplementary Table 4. Comparison of COVID-19 outcomes in those treated with systemic monotherapy vs combination therapy

Files

Institutions

  • Universiteit van Amsterdam

Categories

Systemic Treatment, Atopic Dermatitis, COVID-19

Licence